BSX logo

Boston Scientific (BSX)

Profile

Full Name

Boston Scientific Corporation

Ticker Symbol

BSX

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 19, 1992

Indexes

S&P 500

Website

http://www.bostonscientific.com

Employees

53000

Key Details

Price

$104.80(0.00%)

Market cap

$155.05B(Mega cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$16.75B(+17.61% YoY)

Annual EPS

$1.25(+16.82% YoY)

PE ratio

76.50

Next earnings date

Jul 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$104.80
BSX price is $104.80

30-Day Relative Volume

0.96
BSX 30-day relative volume is 0.96

Price Performance

Price Today change

0%
BSX {parameterFullLabel} is unchanged today

Price YTD change

+17.33%
BSX price is up +17.33% since January 1st

Price 1-year change

+44.11%
BSX price is up +44.11% year-on-year

Price 3-year change

+156.55%
BSX price is up +156.55% over the past 3 years

Price Range

Price All-time high

$107.17
BSX price is currently -2.21% below its historical high of $107.17

Price 3-year low

$34.98
BSX price is currently +199.60% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$155.05B
BSX market capitalization is $155.05 billion

Market cap 3-year change

+165.5%
BSX market capitalization is up +165.5% over the past 3 years

Market cap All-time high

$156.68B
BSX market capitalization is currently -1.04% below its historical high of $156.68 billion

Market cap sector rank

99.1%
BSX market capitalization is higher than 99.1% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.63%
BSX shares outstanding is up +0.63% year-on-year

Shares Outstanding 3-Year Change

+3.49%
BSX shares outstanding is up +3.49% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
BSX beta is 0.74

200-day SMA

$90.99
BSX price is currently +15.18% above its 200-day simple moving average

50-day SMA

$99.23
BSX price is currently +5.62% above its 50-day simple moving average

RSI

64.11
BSX 14-day relative strength index is 64.11

Volume

0.96
BSX 30-day relative volume is 0.96

ATR

$2.11
BSX average true range is $2.11

10-day Historical Volatility

13.41%
BSX 10-day historical volatility is 13.41%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$16.75B
BSX annual revenue is $16.75 billion

Revenue Analysts estimate

$19.47B
BSX annual revenue is currently -13.97% lower than the consensus analysts' forecast

Revenue 1-year change

+17.61%
BSX annual revenue is up +17.61% year-on-year

Revenue Sector rank

95.94%
BSX annual revenue is higher than 95.94% of companies in Healthcare sector

EPS

EPS

$1.25
BSX annual earnings per share is $1.25

EPS Analysts estimate

$2.92
BSX annual earnings per share is currently -57.13% lower than the consensus analysts' forecast

EPS 1-year change

+16.82%
BSX annual earnings per share is up +16.82% year-on-year

EPS Sector rank

90.21%
BSX annual earnings per share is higher than 90.21% of companies in Healthcare sector

Profit

Gross profit

$11.46B
BSX annual gross profit is $11.46 billion

Gross margin

68.41%
BSX annual gross profit margin is 68.41%

Operating profit

$3.00B
BSX annual operating income is $3.00 billion

Operating margin

17.93%
BSX annual operating profit margin is 17.93%

Net income

$1.85B
BSX annual net profit is $1.85 billion

Net margin

11.07%
BSX annual net profit margin is 11.07%

Expenses

Total expenses

$13.74B
BSX annual total expenses is $13.74 billion

Operating expenses

$8.46B
BSX annual total operating expenses is $8.46 billion

Cost of goods sold

$5.29B
BSX annual cost of goods sold is $5.29 billion

Selling, general & administrative expenses

$5.98B
BSX annual SGA is $5.98 billion

Depreciation and amortization

$1.27B
BSX annual depreciation & amortization is $1.27 billion

Interest expense

$305.00M
BSX annual interest expense is $305.00 million

Income tax

$436.00M
BSX annual income tax is $436.00 million

EBIT & EBITDA

EBIT

$2.59B
BSX annual earnings before interest & taxes is $2.59 billion

EBITDA

$3.44B
BSX annual EBITDA is $3.44 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$39.40B
BSX annual total assets is $39.40 billion

Non current assets

$32.48B
BSX annual long term assets is $32.48 billion

Current assets

$6.92B
BSX annual total current assets is $6.92 billion

Cash and cash equivalents

$414.00M
BSX annual cash & cash equivalents is $414.00 million

Accounts receivable

$2.56B
BSX annual accounts receivable is $2.56 billion

Inventory

$2.81B
BSX annual inventory is $2.81 billion

Liabilities

Total liabilities

$17.39B
BSX annual total liabilities is $17.39 billion

Long term liabilities

$10.99B
BSX annual total long term liabilities is $10.99 billion

Current liabilities

$6.40B
BSX annual total current liabilities is $6.40 billion

Accounts payable

$960.00M
BSX annual accounts payable is $960.00 million

Debt

Total debt

$11.15B
BSX annual total debt is $11.15 billion

Total debt 1-year change

+17.44%
BSX annual total debt is up +17.44% year-on-year

Long term debt

$9.37B
BSX annual long term debt is $9.37 billion

Short term debt

$1.78B
BSX annual short term debt is $1.78 billion

Equity & Capital

Shareholders equity

$21.77B
BSX annual stockholders equity is $21.77 billion

Book value

$21.77B
BSX annual book value is $21.77 billion

Retained earnings

$2.67B
BSX annual retained earnings is $2.67 billion

Working capital

$521.00M
BSX annual working capital is $521.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$3.44B
BSX annual cash flow from operations is $3.44 billion

Cash from operations 1-year change

+37.24%
BSX annual cash flow from operations is up +37.24% year-on-year

Cash from investing

-$5.69B
BSX annual cash flow from investing activities is -$5.69 billion

Cash from investing 1-year change

-120.94%
BSX annual cash flow from investing activities is down -120.94% year-on-year

Cash from financing

$1.81B
BSX annual cash flow from financing activities is $1.81 billion

Cash from financing 1-year change

+36180%
BSX annual cash flow from financing activities is up +36180% year-on-year

CAPEX

CAPEX

$1.07B
BSX annual capital expenditures is $1.07 billion

CAPEX 1-year change

+33.75%
BSX annual capital expenditures is up +33.75% year-on-year

Free Cash Flow

Free cash flow

$2.37B
BSX annual free cash flow is $2.37 billion

Free cash flow 1-year change

+38.87%
BSX annual free cash flow is up +38.87% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

68.41%
BSX annual gross profit margin is 68.41%

Operating margin

17.93%
BSX annual operating profit margin is 17.93%

Net margin

11.07%
BSX annual net profit margin is 11.07%

ROA & ROE

ROA

4.98%
BSX annual return on assets is 4.98%

ROE

8.93%
BSX annual return on equity is 8.93%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

76.50
BSX price to earnings ratio is 76.50

PE ratio Sector rank

85.22%
BSX price to earnings ratio is higher than 85.22% of companies in Healthcare sector

PB Ratio

PB ratio

6.98
BSX price to book ratio is 6.98

PB ratio Sector rank

88.04%
BSX price to book ratio is higher than 88.04% of companies in Healthcare sector

PS Ratio

PS ratio

8.83
BSX price to sales ratio is 8.83

PS ratio Sector rank

76.1%
BSX price to sales ratio is higher than 76.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$166.03B
BSX enterprise value is $166.03 billion

Enterprise value Sector rank

99.26%
BSX enterprise value is higher than 99.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

41.71
BSX EV/EBITDA is 41.71

EV/EBITDA Sector rank

96.41%
BSX EV/EBITDA is higher than 96.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.08
BSX annual current ratio is 1.08

Quick ratio

0.64
BSX annual quick ratio is 0.64

Leverage

Debt to equity

0.49
BSX annual debt to equity ratio is 0.49

Interest coverage ratio

8.48
BSX annual interest coverage ratio is 8.48

Risk & Stability

Piotroski F-Score

6
BSX piotroski f-score is 6

Altman Z-Score

6.10
BSX altman z-score is 6.10

Analyst ratings

Recent major analysts updates

Apr 25, 25 Barclays
Overweight
Apr 24, 25 Truist Securities
Buy
Apr 24, 25 RBC Capital
Outperform
Apr 24, 25 Needham
Buy
Apr 24, 25 Evercore ISI Group
Outperform
Apr 24, 25 Baird
Outperform
Apr 16, 25 Needham
Buy
Apr 11, 25 Truist Securities
Buy
Mar 3, 25 Needham
Hold
Feb 10, 25 Stifel
Buy

Institutional Ownership

Similar stocks

TMO logo
Thermo Fisher Scientific (TMO)
AMGN logo
Amgen (AMGN)
SYK logo
Stryker (SYK)
DHR logo
Danaher (DHR)
PFE logo
Pfizer (PFE)
SNY logo
Sanofi (SNY)
GILD logo
Gilead Sciences (GILD)
ISRG logo
Intuitive Surgical (ISRG)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
  • What is the ticker symbol for Boston Scientific?
  • Does Boston Scientific pay dividends?
  • What sector is Boston Scientific in?
  • What industry is Boston Scientific in?
  • What country is Boston Scientific based in?
  • When did Boston Scientific go public?
  • Is Boston Scientific in the S&P 500?
  • Is Boston Scientific in the NASDAQ 100?
  • Is Boston Scientific in the Dow Jones?
  • When was Boston Scientific's last earnings report?
  • When does Boston Scientific report earnings?
  • Should I buy Boston Scientific stock now?

What is the ticker symbol for Boston Scientific?

The ticker symbol for Boston Scientific is NYSE:BSX

Does Boston Scientific pay dividends?

No, Boston Scientific does not pay dividends

What sector is Boston Scientific in?

Boston Scientific is in the Healthcare sector

What industry is Boston Scientific in?

Boston Scientific is in the Medical Devices industry

What country is Boston Scientific based in?

Boston Scientific is headquartered in United States

When did Boston Scientific go public?

Boston Scientific's initial public offering (IPO) was on May 19, 1992

Is Boston Scientific in the S&P 500?

Yes, Boston Scientific is included in the S&P 500 index

Is Boston Scientific in the NASDAQ 100?

No, Boston Scientific is not included in the NASDAQ 100 index

Is Boston Scientific in the Dow Jones?

No, Boston Scientific is not included in the Dow Jones index

When was Boston Scientific's last earnings report?

Boston Scientific's most recent earnings report was on Apr 23, 2025

When does Boston Scientific report earnings?

The next expected earnings date for Boston Scientific is Jul 24, 2025

Should I buy Boston Scientific stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page